The Valley Desk

NCT05093322 · Interventional trial

A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors

Overall registry status Completed

Phase 1 · Phase 2

Conditions Ewing Sarcoma, Lymphoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS), Osteosarcoma, Rhabdomyosarcoma, Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov